FDA Works To Fill Advisory Panel Seats While Tightening Conflict Rules
This article was originally published in The Tan Sheet
Executive Summary
FDA is working on an initiative to bring current advisory committee vacancies from around 30 percent down to 10 percent of its more than 600 spots without backing down from a strict conflict-of-interest policy that many see as contributing to the difficulty in filling the seats